The 4th Annual World ADC Asia 2025 is dedicated to Antibody Drug Conjugates (ADC) drug development.
Topics
- Developing Next Generation ADC Technologies to Develop More Efficacious & Safe Candidates
- Optimizing ADC Format, Target Selection & Combination Strategies to Improve Therapeutic Potential
- Preclinical Strategy for the IND Submission of MRG003 in China
- Analytical & Bioanalytical Considerations for ADCs & Biosimilars
- Optimization of ADCs: Maximizing the Therapeutic Window
- Developing Robust & Scalable ADC Processes to Effectively Outsource Manufacturing
- Exploring Next Generation ADCs in Clinical Development
Who should Attend
Senior attendees from Asia, the US and Europe.